Nexam Chemical has launched a rights issue of up to SEK 51.8m (21,577,544 shares at SEK 2.40) fully covered by SEK 11.4m of subscription commitments and SEK 40.4m of underwriting, with an over-allotment facility of up to SEK 15.0m (6,250,000 shares). Net proceeds are expected to be ~SEK 45.2m after estimated issue costs of SEK 6.6m; funds are earmarked to accelerate the Recycling business and strengthen financial flexibility. Preliminary Q4 2025 revenue was ~SEK 43.5m (Q4 2024: SEK 48.6m) with Recycling contributing ~SEK 8.2m (Q4 2024: SEK 2.3m); FY 2025 net sales are preliminarily ~SEK 192.6m (199.6) and EBITDA ~SEK 3.3m (8.1). The board has called an EGM for 19 Jan 2026 (record date 22 Jan) and advanced the year‑end report to 23 Jan 2026; dilution is up to ~21.1% (up to ~25.6% including full over‑allotment) and up to ~26.4% when factoring potential underwriting compensation in shares.
Market structure: The rights issue front-loads capital (SEK51.8m base, +SEK15.0m over-allotment) to accelerate the Recycling segment which grew to ~SEK23m FY2025 and is targeted to double in 2026. Winners: Nexam’s Recycling unit, commercial partners in recycled polymers and underwriters (fees ~SEK3m cash or equity); losers: non-participating shareholders facing 21.1–25.6% dilution and near-term liquidity sellers. The move modestly increases share float and should boost Nexam’s pricing power in niche additives if execution matches guidance; broader specialty-chemical pricing dynamics unchanged. Risk assessment: Key tail risks are (1) FDI-screen blocking >10% subscriptions (must notify ISP) delaying funding, (2) underwriters failing to fulfill non-guaranteed commitments, and (3) execution risk in converting Recycling demand into gross-margin-bearing volume. Immediate catalysts: EGM 19 Jan, InfoDoc and year-end report 23 Jan, rights trading 26 Jan–4 Feb, outcome 11 Feb. Medium-term risk: failure to achieve 2x Recycling revenue in 2026 would force follow-on raises and further dilution. Trade implications: Tactical plays center on capital structure mechanics: pro-rata participation is the lowest-cost way to avoid a ~0.64 SEK dilution-cost per existing share (4/15 * SEK2.40). Active traders can use subscription rights (TR, 26 Jan–4 Feb) as a levered, capped-risk exposure; size to 1–2% NAV and target 25–40% event-driven returns into the 11 Feb outcome. For hedged investors, consider shorting liquidity-sensitive small-cap Swedish specialty-chemical peers if uptake disappoints and pair long Nexam Recycling exposure vs short larger cap chemical (e.g., Covestro 1COV.DE) to isolate execution alpha. Contrarian angle: The market may over-emphasize dilution while underpricing the 2026 growth vector — insiders and key shareholders have committed ~22% subscription and substantial top underwritings, which signals management conviction. Conversely, the absence of guaranteed bank escrow for underwritings is a real weakness: if ISP delays or one large underwriter balks, the issue could become a liquidity trap. Historical parallel: successful niche-technology turnarounds funded by rights show >50% upside only when commercial KPIs (recurring volumes, multi-customer contracts) are visible within 6–12 months — watch for that evidence, not just revenue guidance.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.22